GHK-Cu: the copper peptide in recent skin-repair research
Research summary. Everything below describes published research on GHK-Cu (copper tripeptide-1) as a compound. Nothing here is advice, and no outcome, benefit or dose is implied for any person. Products are supplied for laboratory research use only, not for human consumption.
GHK-Cu, the copper tripeptide, is one of the most-studied compounds in skin and tissue-repair research, and materials scientists keep finding new ways to work with it. A 2026 study is a good example.
A smart hydrogel that releases GHK-Cu on cue
Researchers developed an injectable, pH-responsive hydrogel carrying carbon dots plus the GHK-Cu complex, and tested it on radiation-induced skin injury in mice (Bioactive Materials, 2026).
They reported a two-stage design: the carbon dots released first to mop up reactive oxygen species in the acidic wound, after which GHK-Cu released to support tissue repair and collagen deposition. It is an animal and materials study, describing how the compound behaved within that delivery system.
Source: Bioactive Materials, 2026
A note on the copper-peptide family
A related 2026 materials study grafted GHK-Cu onto nanofibrous polypeptide microspheres and reported enhanced bone-forming cell activity plus pro-angiogenic signalling in a cell and material setting. It is worth noting the closely related peptide AHK-Cu is a different copper tripeptide, and this particular work was on GHK-Cu specifically.
Source: Biomaterials Advances, 2026
The compounds at Revexa
AHK-Cu 50mg (the related copper tripeptide)
All products at Revexa are supplied strictly for laboratory and research use only. Not for human or veterinary use, and not for consumption. The research described above is reported as published, in the models the original authors studied, and must not be read as a claim, benefit or instruction for any individual.
Comments